If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 67   2006   NUMBER 4

Original Articles

509 Atypical Antipsychotics in the Treatment of Mania: A Meta-Analysis of Randomized, Placebo-Controlled Trials. [CME] Roy H. Perlis, Jeffrey A. Welge, Lana A. Vornik, Robert M. A. Hirschfeld, and Paul E. Keck, Jr.
[Abstract] [PDF]

517 Suicide Rates in Relation to Health Care Access in the United States: An Ecological Study. Leonardo Tondo, Matthew J. Albert, and Ross J. Baldessarini
[Abstract] [PDF]

524 Functional Impairments in Adults With Self-Reports of Diagnosed ADHD: A Controlled Study of 1001 Adults in the Community. Joseph Biederman, Stephen V. Faraone, Thomas J. Spencer, Eric Mick, Michael C. Monuteaux, and Megan Aleardi
[Abstract] [PDF]

541 Neurologic Soft Signs in Borderline Personality Disorder. José Manuel De la Fuente, Julio Bobes, Coro Vizuete, Maria-Teresa Bascaran, Ignacio Morlán, and Julien Mendlewicz
[Abstract] [PDF]

547 Weight Management Program for Treatment-Emergent Weight Gain in Olanzapine-Treated Patients With Schizophrenia or Schizoaffective Disorder: A 12-Week Randomized Controlled Clinical Trial. Jun Soo Kwon, Jung-Seok Choi, Won-Myoung Bahk, Chang Yoon Kim, Chan Hyung Kim, Young Chul Shin, Byung-Joo Park, and Chang Geun Oh
[Abstract] [PDF]

554 A Systematic Review of Modafinil: Potential Clinical Uses and Mechanisms of Action. Jacob S. Ballon and David Feifel
[Abstract] [PDF]

567 Characterizing Impaired Driving in Adults With Attention-Deficit/Hyperactivity Disorder: A Controlled Study. Ronna Fried, Carter R. Petty, Craig B. Surman, Bryan Reimer, Megan Aleardi, Jessica M. Martin, Joseph F. Coughlin, and Joseph Biederman
[Abstract] [PDF]

575 Metabolic Syndrome and the Risk of Coronary Heart Disease in 367 Patients Treated With Second-Generation Antipsychotic Drugs. Christoph U. Correll, Anne M. Frederickson, John M. Kane, and Peter Manu
[Abstract] [PDF]

584 Differences in Axis I and II Comorbidity Between Bipolar I and II Disorders and Major Depressive Disorder. Outi Mantere, Tarja K. Melartin, Kirsi Suominen, Heikki J. Rytsälä, Hanna M. Valtonen, Petri Arvilommi, Sami Leppämäki, and Erkki T. Isometsä
[Abstract] [PDF]

594 Psychiatric Comorbidity in Binge-Eating Disorder as a Function of Smoking History. [CME] Marney A. White and Carlos M. Grilo
[Abstract] [PDF]

600 Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Obsessive-Compulsive Disorder: A Critical Review. Bernardo Dell'Osso, Gerald Nestadt, Andrea Allen, and Eric Hollander
[Abstract] [PDF]

611 A Randomized Double-Blind Trial of Paroxetine and/or Dextroamphetamine and Problem-Focused Therapy for Attention-Deficit/Hyperactivity Disorder in Adults. Margaret Weiss, Lily Hechtman, and The Adult ADHD Research Group
[Abstract] [PDF]

620 Moral Objections to Suicide: Can They Counteract Suicidality in Patients With Cluster B Psychopathology? Kanita Dervic, Maria A. Oquendo, Dianne Currier, Michael F. Grunebaum, Ainsley K. Burke, and J. John Mann
[Abstract] [PDF]

626 A Randomized, Double-Blind, Placebo-Controlled 26-Week Trial of Aripiprazole in Recently Manic Patients With Bipolar I Disorder. Paul E. Keck, Jr., Joseph R. Calabrese, Robert D. McQuade, William H. Carson, Berit X. Carlson, Linda M. Rollin, Ronald N. Marcus, and Raymond Sanchez, for the Aripiprazole Study Group
[Abstract] [PDF]

638 Efficacy of Ziprasidone Against Hostility in Schizophrenia: Post Hoc Analysis of Randomized, Open-Label Study Data. Leslie Citrome, Jan Volavka, Pal Czobor, Shlomo Brook, Antony Loebel, and Francine S. Mandel
[Abstract] [PDF]

643 Factors Associated With Temporal Priority in Comorbid Bipolar I Disorder and Alcohol Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. Benjamin I. Goldstein and Anthony J. Levitt
[Abstract] [PDF]

Focus on Alzheimer's Disease and Related Disorders

650 In This Issue: The Genetic, Transcriptomic, and Proteomic Study of Alzheimer's Disease. Eric M. Reiman
[PDF]

652 Genetics, Transcriptomics, and Proteomics of Alzheimer's Disease. Andreas Papassotiropoulos, Michael Fountoulakis, Travis Dunckley, Dietrich A. Stephan, and Eric M. Reiman
[Abstract] [PDF]

ASCP Corner

671 Novel Transdermal Delivery Formulation of the Monoamine Oxidase Inhibitor Selegiline Nearing Release for Treatment of Depression. Michael E. Thase
[PDF]

Letters To the Editor

673 Simultaneous True Seizures and Pseudoseizures. Chittaranjan Andrade, Nagendra M. Singh, and Savita G. Bhakta
[PDF]

673 The Emergence of Darkness Phobia in a Bipolar Patient During Quetiapine Treatment. Maria Teresa Plana, Anna Mane, Antoni Benabarre, Jose M. Goikolea, and Eduard Vieta
[PDF]

674 High-Dose Aripiprazole in Treatment-Resistant Schizophrenia. Harpeet S. Duggal and Dattatreya N. Mendhekar
[PDF]

675 Clozapine Augmentation With Aripiprazole for Negative Symptoms. Laura A. Clarke, Jean-Pierre Lindenmayer, and Saurabh Kaushik
[PDF]

677 Early Bicarbonate Loading and Dantroline for Ziprasidone/Haloperidol-Induced Neuroleptic Malignant Syndrome. Jeffrey R. Strawn and Paul E. Keck, Jr.
[PDF]

Book Reviews 678